Prosecution Insights
Last updated: November 04, 2026
Application No. 19/044,305

GUIDEWIRE FOR IMAGING AND MEASUREMENT OF PRESSURE AND OTHER PHYSIOLOGICAL PARAMETERS

Final Rejection §103
Filed
Feb 03, 2025
Priority
Mar 20, 2020 — provisional 62/992,695 +4 more
Examiner
BRUTUS, JOEL F
Art Unit
3797
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Xenter Inc.
OA Round
2 (Final)
73%
Grant Probability
Favorable
3-4
OA Rounds
1y 8m
Est. Remaining
91%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allowance Rate
961 granted / 1319 resolved
+2.9% vs TC avg
Strong +18% interview lift
Without
With
+17.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
35 currently pending
Career history
1363
Total Applications
across all art units

Statute-Specific Performance

§101
7.5%
-32.5% vs TC avg
§103
51.7%
+11.7% vs TC avg
§102
13.9%
-26.1% vs TC avg
§112
20.2%
-19.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1319 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-3, 5-12 are rejected under 35 U.S.C. 103 as being unpatentable over Carreel et al (Pub. No.: US 2019/0380651) in view of Degerteken et al (Pub. No.: US 2014/0236017) Regarding claims 1-2, Carreel et al disclose a guidewire for use within an intraluminal space of a body, comprising: an elongated wire having a proximal end and a distal end [see 0008, 0080, claim 60, fig 2]; circuitry at or near the distal end of the elongated wire, comprising: a flexible substrate (flexible circuit/substrate) having a plurality of conductive traces (conductive pads, see claim 41) and wrapped about a portion of the elongated wire [see 0076, 0168, 0176] by disclosing the flexible circuit further comprises thereon a plurality of conductive pads configured to be bonded to respective wire leads [see claim 41]; a plurality of pressure sensors (212/302/25) associated with the flexible and spaced along a length of the elongated wire [see 0118, 0140, 0176 and figs 2-3] by disclosing sensor array 25 may include a plurality of sensors for sensing one or more characteristics of the tissues surrounding the guidewire such as pressure sensors [see 0176]; at least one circuit (via a power cable) configured to receive power from a power source [see 0124] and distribute the power among the plurality of pressure sensors [see 0124]. wherein a cross-sectional area of the guidewire is approximately 0.014 inch [see 0075, fig 33]. Carreel et al don’t disclose the flexible substrate exhibiting a cut-seam that is circumferentially distributed about the portion and wherein the flexible substrate is helically wound about the portion of the elongated wire Nonetheless, Degerteken et al flexible substrate (coil) exhibiting a cut-seam that is circumferentially distributed about the portion and wherein the flexible substrate is helically wound about the portion of the elongated wire [see 0053, figs 2A]. Therefore, it is obvious to one skilled in the art at the time the invention was filed and would have been motivated to combine Carreel et al and Idstrom by using flexible substrate exhibiting a cut-seam that is circumferentially distributed about the portion and the flexible substrate is helically wound about the portion of the elongated wire; to deform to a defined shape. Regarding claim 3, Carreel et al disclose an outer member disposed over the flexible substrate [see 0333]. Regarding claim 5, Carreel et al disclose wherein the at least one circuit includes at least one application-specific integrated circuit [see 0117]. Regarding claim 6, Carreel et al disclose wherein the at least one circuit includes at least one field-programmable gate array [see 0380]. Regarding claim 7, Carreel et al disclose wherein the plurality of sensors includes at least one pressure sensor [see 0176] by disclosing sensor array 25 may include a plurality of sensors for sensing one or more characteristics of the tissues surrounding the guidewire such as pressure sensors [see 0176]. Regarding claims 8, 12, Carreel et al don’t disclose wherein the plurality of sensors includes at least one ultrasound imaging sensor; wherein the plurality of sensors includes at least one pressure sensor and at least one imaging sensor. Nonetheless, Degerteken et al disclose wherein the plurality of sensors includes at least one ultrasound imaging sensor [see 0062-0063 and fig 4]; wherein the plurality of sensors includes at least one pressure sensor and at least one imaging sensor [see 0062-0063 and fig 4] by disclosing a capacitive pressure sensing FFR membrane (basically a large CMUT) 225 and capacitive sensor electronics can easily be integrated into the chip 215 and the FFR sensor can be a piezoresistive sensor on the same chip as the CMUT imaging chip or it can be on a separate chip but electrically and mechanically connected to the CMUT imaging chip [see 0062]. Therefore, it is obvious to one skilled in the art at the time the invention was filed and would have been motivated to combine Carreel et al and Degerteken et al by using at least one ultrasound imaging sensor and at least one pressure sensor; for direct pressure and/or temperature measurement and enable the guidewire to be tracked via ultrasound imaging. Regarding claim 9-11, Carreel et al don’t disclose wherein the at least one ultrasound imaging sensor is operable with a center frequency of about 5 MHz to about 25 MHz; wherein the at least one ultrasound imaging sensor is operable with a center frequency of about 8 MHz to about 20 MHz and wherein the at least one ultrasound imaging sensor is operable with a center frequency of about 10 MHz to about 15 MHz. Nonetheless, Degerteken et al disclose wherein the at least one ultrasound imaging sensor is operable with a center frequency of about 5 MHz to about 25 MHz; wherein the at least one ultrasound imaging sensor is operable with a center frequency of about 8 MHz to about 20 MHz and wherein the at least one ultrasound imaging sensor is operable with a center frequency of about 10 MHz to about 15 MHz [see 0058]. Therefore, it is obvious to one skilled in the art at the time the invention was filed and would have been motivated to combine Carreel et al and Degerteken et al by having at least one ultrasound imaging sensor is operable with a center frequency of about 5 MHz to about 25 MHz; wherein the at least one ultrasound imaging sensor is operable with a center frequency of about 8 MHz to about 20 MHz and wherein the at least one ultrasound imaging sensor is operable with a center frequency of about 10 MHz to about 15 MHz; to improve the image resolution and provide clinical quality ultrasound images in 20 MHz [see 0064]. Claim(s) 4 is rejected under 35 U.S.C. 103 as being unpatentable over Carreel et al (Pub. No.: US 2019/0380651) in view of Degerteken et al (Pub. No.: US 2014/0236017) as applied to claim 3 above and further in view of Marmur et al (Pub. No.: US 2018/0021157). Regarding claim 4, Carreel et al don’t disclose wherein the outer member comprises polyethylene terephthalate of polyether block amide. Nonetheless, Marmur et al disclose wherein the outer member comprises polyethylene terephthalate of polyether block amide [see 0031] Therefore, it is obvious to one skilled in the art at the time the invention was filed and would have been motivated to combine Carreel et al and Degerteken et al and Marmur et al by using polyethylene terephthalate of polyether block amide; The polyamide component provides the strength, thermal stability, and chemical resistance, while the polyether component lends flexibility, low-temperature performance, and hydrophilicity to the compound. Response to Arguments Applicant’s arguments, see REM, filed 6/29/2026, with respect to the rejection(s) of claim(s) 1 Under 102 have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new ground(s) of rejection is made in view of Degerteken et al (Pub. No.: US 2014/0236017). Applicant argues the flexible substrate exhibiting a cut-seam that is circumferentially distributed about the portion and wherein the flexible substrate is helically wound about the portion of the elongated wire. Nonetheless, Degerteken et al flexible substrate (coil) exhibiting a cut-seam that is circumferentially distributed about the portion and wherein the flexible substrate is helically wound about the portion of the elongated wire [see 0053, figs 2A]. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOEL F BRUTUS whose telephone number is (571)270-3847. The examiner can normally be reached Mon-Sat, 11:00 AM to 7:00 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anne Kozak can be reached at 571-270-0552. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JOEL F BRUTUS/ Primary Examiner, Art Unit 3797
Read full office action

Prosecution Timeline

Feb 03, 2025
Application Filed
Jan 28, 2026
Non-Final Rejection mailed — §103
Jun 29, 2026
Response Filed
Sep 10, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12778626
TRANSPERINEAL PROSTATE BIOPSY AND TREATMENT SYSTEMS
1y 11m to grant Granted Nov 03, 2026
Patent 12778684
System And Method For Performing And Evaluating A Procedure
1y 9m to grant Granted Nov 03, 2026
Patent 12778559
MEDICAL IMAGING SYSTEM, CONTROL METHOD THEREFOR, AND NON-TRANSITORY COMPUTER-READABLE MEDIUM
1y 7m to grant Granted Nov 03, 2026
Patent 12773319
CERAMIC JOINT IMPLANT PROVIDED WITH LOCKING DEVICE FOR SCREWING IT
3y 0m to grant Granted Oct 27, 2026
Patent 12762703
ENDOSCOPE PROCESSOR, METHOD FOR OPERATING ENDOSCOPE PROCESSOR, AND STORAGE MEDIUM
1y 10m to grant Granted Oct 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
73%
Grant Probability
91%
With Interview (+17.7%)
3y 5m (~1y 8m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1319 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month